Related Experiment Video
Updated: Oct 3, 2026

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Published on: November 23, 2013
GluR3 antibodies: prevalence in focal epilepsy but no specificity for Rasmussen's encephalitis
H Wiendl1, C G Bien, P Bernasconi
1Department of Neurology, University of Tübingen, Germany. heinz.wiendl@uni-tuebingen.de
Abstract:
Eight patients with Rasmussen's encephalitis, 40 patients with noninflammatory focal epilepsy, 104 patients with various neurologic diseases, and 16 healthy donors were tested for the prevalence of antibodies against the GluR3 receptor in serum and CSF. Reactivities against different peptides derived from various portions of this glutamate receptor subtype were detectable in a significantly higher number of patients with focal epilepsy than in those with other neurologic diseases, but they were not specific for the diagnosis of Rasmussen's encephalitis.
More Related Videos
08:20Hippocampal Neuronal Cultures to Detect and Study New Pathogenic Antibodies Involved in Autoimmune Encephalitis
Published on: June 2, 2022
07:20A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate (NMDA) Receptor in Blood
Published on: January 9, 2018
Related Concept Videos
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology
Antiepileptic Drugs: Glutamate Antagonists
Arboviral Encephalitis
Rocky Mountain Spotted Fever